Zimitrax at a Glance
Zimitrax 100 mg is a pharmaceutical-grade cefixime preparation manufactured by Signature Pharmaceuticals Ltd. Cefixime is a third-generation cephalosporin antibiotic compound extensively studied in microbiological research for its broad-spectrum antimicrobial properties and beta-lactam resistance mechanisms. Research scientists at Stroid UK Shop utilise this compound to investigate bacterial cell wall synthesis inhibition, pharmacokinetic properties, and antimicrobial resistance patterns in controlled laboratory environments. The 100 mg formulation provides researchers with standardised dosing for reproducible experimental protocols.
Laboratory Applications
Cefixime research encompasses multiple areas of microbiological investigation including bacterial resistance mechanism studies, minimum inhibitory concentration (MIC) determinations, and pharmacodynamic modelling. Researchers examine this cefixime preparation for its activity against gram-positive and gram-negative bacterial strains, particularly in studying extended-spectrum beta-lactamase (ESBL) producing organisms. The compound’s oral bioavailability characteristics make it valuable for pharmacokinetic research protocols. Laboratory studies also investigate synergistic interactions with other antimicrobial agents and resistance prevention strategies. Unlike SARMs research focusing on selective receptor modulation, cefixime studies concentrate on antimicrobial mechanisms and bacterial cell wall disruption pathways. Research applications extend to biofilm penetration studies and combination therapy investigations with peptides showing antimicrobial properties.
Compound Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Cefixime |
| Strength | 100 mg |
| Manufacturer | Signature Pharmaceuticals Ltd. |
| Form | Pharmaceutical tablet |
| CAS Number | 79350-37-1 |
| Molecular Formula | C₁₆H₁₅N₅O₇S₂ |
| Molecular Weight | 453.45 g/mol |
| Storage | Room temperature, dry conditions |
Research Compliance
Zimitrax 100 mg is supplied exclusively for in-vitro laboratory research and microbiological studies. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must comply with institutional guidelines for antimicrobial compound handling and disposal. All studies should follow established laboratory protocols for bacterial culture work and antimicrobial susceptibility testing procedures.
